MedPath

Study of Modified Constraint-Induced Aphasia Therapy Schedule to Treat Patients Following Sub-acute Stroke

Not Applicable
Completed
Conditions
Aphasia
Registration Number
NCT01625676
Lead Sponsor
NRZ Magdeburg Median Kliniken GmbH & Co
Brief Summary

The purpose of this study is to assess the feasibility of modified Constraint-Induced Aphasia Therapy (CIAT) in the early sub-acute stage and to examine the efficacy of modified CIAT versus standard treatment with the same intensity of intervention.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
100
Inclusion Criteria
  • clinical diagnosis of first-ever stroke
  • aphasia in sub-acute stage
  • german speakers
Exclusion Criteria
  • presence of residual aphasia
  • dysarthria and apraxia of speech

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Change of aphasia and aphasic syndromes by Aachen Aphasia Test (AAT)pretreatment and 4 weeks
change from pretreatment in Aachen Aphasia Test at 8 weekspretreatment and 8 weeks
change from pretreatment in Aachen Aphasia Test at 1 yearpretreatment and 1 year
Secondary Outcome Measures
NameTimeMethod
Change of Communicative Activity (CAL)pretreatment and 4 weeks
change from pretreatment in communication activity (CAL)at 8 weekspretreatment and 8 weeks
Change from pretreatment in communication activity (CAL)at 1 yearpretreatment and 1 year

Trial Locations

Locations (1)

NRZ Median Klinik

🇩🇪

Magdeburg, Germany

NRZ Median Klinik
🇩🇪Magdeburg, Germany

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.